Health Industry Updates: Major Acquisitions and Policy Challenges

Source Summary

In recent health news, Vertex Pharmaceuticals plans a $10 billion acquisition of Crinetics for rare diseases. The US announces $281 million for mental health programs, while Congo faces rising Ebola cases. Novartis is set to acquire UK’s Myricx Bio for cancer drug development. Meanwhile, India's legal changes raise concerns for transgender patients.